ATRX guards against aberrant differentiation in mesenchymal progenitor cells

Alterations in the tumor suppressor ATRX are recurrently observed in several cancer types including sarcomas, which are mesenchymal neoplasms. ATRX has multiple epigenetic functions including heterochromatin formation and maintenance and regulation of transcription through modulation of chromatin ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yan, Barrows, Douglas, Dabas, Yakshi, Carroll, Thomas S, Tap, William D., Nacev, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441338/
https://www.ncbi.nlm.nih.gov/pubmed/37609273
http://dx.doi.org/10.1101/2023.08.08.552433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441338/
https://www.ncbi.nlm.nih.gov/pubmed/37609273
http://dx.doi.org/10.1101/2023.08.08.552433

Ejemplares similares